You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

heterogenous clonal diseases neoplasms

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ctDNA Methylation Sequencing for Myeloma

Recruiting
  • Multiple Myeloma
  • plasma circulation DNA methylation sequencing
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
Oct 11, 2022

Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms

Not yet recruiting
  • Pyruvate Kinase Deficiency
  • +10 more
  • Blood Draw
  • Boston, Massachusetts
    Massachusetts General Hospital
May 21, 2021

MDS Trial run by the National Cancer Institute (NCI) (decitabine and cedazuridine, BMS-986253)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles

Not yet recruiting
  • Clonal Cytopenia of Undetermined Significance
  • +4 more
  • Biospecimen Collection
  • +6 more
  • Los Angeles, California
  • +1 more
Oct 4, 2023

MDS/MPN Trial in Nanjing (Azacitidine (AZA) with Ruxolitinib)

Recruiting
  • MDS/MPN
  • Azacitidine (AZA) with Ruxolitinib
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Apr 17, 2023

In Situ Clonal Heterogeneity in Prostatic Diagnostic Biopsies

Recruiting
  • Prostate Cancer
  • Genetic Predisposition
  • clonal heterogeneity evaluation
  • Lugano, Ticino, Switzerland
    Alessandra Franzetti Pellanda
Jul 19, 2022

Relapsed or Resistant Acute Leukaemias Trial in Australia, Taiwan (LBS-007)

Not yet recruiting
  • Relapsed or Resistant Acute Leukaemias
  • Adelaide, Australia
  • +3 more
Feb 23, 2023

MDS, Ferroptosis Trial in Pessac (Biological sampling)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Ferroptosis
  • Biological sampling
  • Pessac, France
  • +2 more
Jun 19, 2023

Chromogranin A as Blood Marker in Cancer Patients

Completed
  • Gastric Neoplasms
  • +3 more
  • BRAHMS CgA II KRYPTOR
  • Palo Alto, California
  • +3 more
Dec 19, 2022

Parathyroid Tumor Clonal Status

Active, not recruiting
  • Parathyroid Tumor
  • Primary Hyperparathyroidism
    • Birmingham, Alabama
    • +2 more
    Aug 11, 2023

    Reduce Need for Diagnostic EUS or MRCP in Intermediate

    Not yet recruiting
    • Choledocholithiasis
      • (no location specified)
      Sep 27, 2023

      Epigenetic Age on Clinic-biological Presentation and Prognosis

      Not yet recruiting
      • Myeloproliferative Neoplasm
      • Assessment of the epigenetic age
      • Bordeaux, France
        CHU de Bordeaux, service Hématologie Biologique
      Aug 28, 2023

      Non-Hodgkin Lymphoma Trial in Sohag (real time pcr)

      Not yet recruiting
      • Non-Hodgkin Lymphoma
      • real time pcr
      • Sohag, Egypt
        Sohag University
      Jun 27, 2023

      Immune System Diseases, Autoimmune Diseases, Inflammation Trial (observational cohort study)

      Not yet recruiting
      • Immune System Diseases
      • +15 more
      • observational cohort study
      • (no location specified)
      Jul 23, 2023

      Venous Thromboses, Thromboembolic Disease, Neutrophil Extracellular Trap Formation Trial in Bordeaux (Additional blood sampling)

      Not yet recruiting
      • Venous Thromboses
      • +3 more
      • Additional blood sampling
      • Bordeaux, France
      • +7 more
      Jan 24, 2023

      Constipation, Fecal Incontinence Trial (Low-volume irrigation)

      Not yet recruiting
      • Constipation
      • Fecal Incontinence
      • Low-volume irrigation
      • (no location specified)
      Mar 15, 2023

      Myelofibrosis Trial in France (Clonal architecture determination)

      Not yet recruiting
      • Myelofibrosis
      • Clonal architecture determination
      • Angers, France
      • +6 more
      Jan 24, 2023

      Pain Trial in France (Management pain with distraction methods ABC, Management pain with distraction methods BCA, Management

      Recruiting
      • Pain
      • Management pain with distraction methods ABC
      • +2 more
      • Hyères, France
      • +7 more
      Sep 6, 2022

      Philadelphia Negative Myeloproliferative Tumors Trial

      Not yet recruiting
      • Philadelphia Negative Myeloproliferative Neoplasms
        • (no location specified)
        Jun 5, 2022

        MDS Trial (Fasting-mimicking diet (FMD) and physiotherapy)

        Not yet recruiting
        • Myelodysplastic Syndromes
        • Fasting-mimicking diet (FMD) and physiotherapy
        • (no location specified)
        Jun 22, 2022

        Early Calcific Aortic Valve Disease in Bicuspid Aortic Valve

        Recruiting
        • Bicuspid Aortic Valve
          • Seoul, Korea, Republic of
            Division of Cardiology, Yonsei University Health System, Yonsei
          Nov 30, 2023

          Myeloproliferative Tumor, Secondary Leukemia Trial (Multiomic characterization, In vitro drug screening)

          Not yet recruiting
          • Myeloproliferative Neoplasm
          • Secondary Leukemia
          • Multiomic characterization
          • In vitro drug screening
          • (no location specified)
          Aug 28, 2023

          CHIP in Endothelial Dysfunction Associated With HEpEF

          Not yet recruiting
          • Heart Failure With Preserved Ejection Fraction
            • (no location specified)
            Apr 12, 2023

            The Myeloid Neoplasms Biology and Outcome Project

            Recruiting
            • Myeloid Neoplasm
              • Heidelberg, Baden-Württemberg, Germany
                UHHeidelberg
              Nov 21, 2022

              BRIEF TITLE * Role of MRI in Anti-LGI1 Encephalitis

              Completed
              • Autoimmune Encephalitis
              • Retrospective evaluation of specific brain MRI features
              • Lyon, France
                Centre de référence des syndromes neurologiques paranéoplasiques
              Apr 20, 2023